WHAT ARE VASCULAR ACCESS DEVICES?
A vascular access device is a medical device that’s purpose is to access a patient’s veins and arteries. Additionally, vascular access accessories are used to improve safety and overall performance. Catheters are one of the main vascular access devices used and their indications for use include the administration of drugs, blood drawing, and hemodialysis. Single-use, disposable vascular access accessories are also used quite frequently. These accessories include catheter securement devices, antibacterial catheter patches, and disinfecting catheter caps. Two segments tend to be of specific interest and are the main topics of this blog: the peripherally inserted central catheter (PICC) segment and the peripheral intravenous catheter (PIVC) segment. Below, the top competitors and the products that they offer for both the U.S. PICC and the PIVC markets are discussed. Continue reading to learn more.
WHO ARE THE TOP COMPETITORS IN THE U.S. PIVC MARKET AND WHAT DO THEY OFFER?
Peripheral intravenous catheters (PIVCs) are the most common vascular access catheters in hospitals, accounting for 95% of vascular access devices used. Typically, these devices are intended for short-term use, usually no longer than three days. Leading the market, BD and B. Braun are the top two competitors.
BD was the overall leader in the PIVC market, and has historically been a leader in the PIVC market in the U.S. In terms of product offerings, the company offers a vast array of PIVCs. A few of BD’s products include its AngiocathTM IV catheters, including the Angioguard and Insyte Autoguard catheters. Previously, the Insyte Autoguard generated the most revenue and unit share out of all the company’s catheter products.
On the other hand, B. Braun comes in as the second-most leader in the US PIVC market. B. Braun was able to leverage the power of a lower price point to increase unit sales volume and drive revenue. In terms of products, B. Braun offers a few catheters products but not nearly as many as BD. B. Braun currently offers its Introcan Safety IV Catheters and the Introcan Safety 3 Closed IV Catheters. Overall, the most successful product in terms of revenue and unit share within this market segment for B. Braun is its Introcan Safety Catheter.
WHO ARE THE TOP COMPETITORS IN THE U.S. PICC MARKET AND WHAT DO THEY OFFER?
Peripherally inserted catheters (PICCs) are introduced through the basilic, cephalic, or median cubital veins in the arm, and the tip of the catheter is then directed to the superior vena cava (SVC). Generally, these devices are used for one week to three months but can range in use from a few days to over a year. This flexibility sets PICCs apart from other vascular access catheters and contributes to the increased use of PICCs in general. One company in particular dominates the U.S. PICC market and, as possibly expected, is BD.
BD was able to gain a leading position within the PICC market following the company’s acquisition of C. R. Bard. This acquisition allowed the company to leverage an extensive PICC portfolio and market leading tip-confirmation technology to capture a dominant share in the U.S. market. BD’s acquired product line can be divided between those used by interventional radiologists and those used by nurses. In terms of overall revenue and unit share, BD’s PowerPICC Provena performed the best and generated the highest numbers.
Subsequently, Teleflex Medical was the second-largest player in the U.S. PICC market. Similarly to BD, Teleflex acquired Arrow International and has since been selling Arrow’s former line of products including power-injectable PICCs and triple-lumen power-injectable PICCs. Teleflex has comparable unit sales to AngioDynamics, both of which are much less than BD, yet Teleflex has not been able to be as successful as BD. When looking at revenue and unit share, the Arrowg+ard Blue Advance PICC performed the best overall for Teleflex in the U.S. PICC market.
While the U.S. vascular access market has been maturing in certain segments, such as the PICC segment, companies are starting to actively invest in the development of new technological features. PIVCs are similarly seeing growth and a moderate increase over the forecast period which will largely be driven by gains in the value of the safety PIVC segment.
All of our specific product, revenue, and unit share insights have been drawn from our MedSKU solution. MedSKU is an accurate brand-level custom solution that provides a level of detail for a go-to strategy of medical device companies of any size. The brand and SKU-level consulting service is tailored to your exact needs so you don’t have to waste time sifting through piles of unnecessary and misleading datasets or paying for information you do not need. If you find yourself wanting to explore the MedSKU solution even further, click on the button below.